Authors

• Farhad Ravandi (ORCID: https://orcid.org/0000-0002-7621-377X)
• Courtney Denton Dinardo (ORCID: https://orcid.org/0000-0001-9003-0390)
• Prithviraj Bose (ORCID: https://orcid.org/0000-0002-4343-5712)
• Steven Mitchell Kornblau (ORCID: https://orcid.org/0000-0002-5990-9548)
• Tapan Mahendra Kadia (ORCID: https://orcid.org/0000-0002-9892-9832)
• Guillermo Montalban‐Bravo (ORCID: https://orcid.org/0000-0002-4533-5176)
• Koji Sasaki (ORCID: https://orcid.org/0000-0002-9140-0610)
• Sherry A. Pierce (ORCID: https://orcid.org/0000-0002-9542-1558)
• Hui Yang (ORCID: https://orcid.org/0000-0002-6125-5985)
• Elias Joseph Jabbour (ORCID: https://orcid.org/0000-0003-4465-6119)
• Ian Bouligny (ORCID: https://orcid.org/0000-0002-4274-4249)
• Chitra Hosing (ORCID: https://orcid.org/0000-0003-0409-5556)
• Koichi Takahashi (ORCID: https://orcid.org/0000-0002-8027-9659)
• Gautam M. Borthakur (ORCID: https://orcid.org/0000-0001-7679-6453)
• Rashmi Kanagal‐Shamanna (ORCID: https://orcid.org/0000-0001-7829-5249)
• Alexandre Bazinet (ORCID: https://orcid.org/0000-0001-5538-4943)
• Guillermo Garcia‐Manero (ORCID: https://orcid.org/0000-0002-3631-2482)
• Xuelin Huang (ORCID: https://orcid.org/0000-0001-6545-9654)
• Yesid Alvarado (ORCID: https://orcid.org/0000-0002-1652-7937)
• Michael Andreeff (ORCID: https://orcid.org/0000-0002-1144-1958)
• Lucia Masárová (ORCID: https://orcid.org/0000-0001-6624-4196)
• Naveen Pemmaraju (ORCID: https://orcid.org/0000-0002-1670-6513)
• Meghan Meyer
• Naval Daver

Institutions

• The University of Texas MD Anderson Cancer Center (US)

Publication Details

Journal

Haematologica

Published

2025-02-20

DOI

https://doi.org/10.3324/haematol.2024.286559

Citations

2

Primary Topic

Chronic Myeloid Leukemia Treatments

Type

article

Field-Weighted Citation Impact

3.54

Funders

• Bristol-Myers Squibb
• National Institutes of Health
• University of Texas MD Anderson Cancer Center
• National Cancer Institute